73 related articles for article (PubMed ID: 12920316)
1. Crystal structures of Tcl1 family oncoproteins and their conserved surface features.
Petock JM; Torshin IY; Wang YF; Du Bois GC; Croce CM; Harrison RW; Weber IT
ScientificWorldJournal; 2002 Jul; 2():1876-84. PubMed ID: 12920316
[TBL] [Abstract][Full Text] [Related]
2. Structure of murine Tcl1 at 2.5 A resolution and implications for the TCL oncogene family.
Petock JM; Torshin IY; Wang YF; Du Bois GC; Croce CM; Harrison RW; Weber IT
Acta Crystallogr D Biol Crystallogr; 2001 Nov; 57(Pt 11):1545-51. PubMed ID: 11679718
[TBL] [Abstract][Full Text] [Related]
3. A modeled hydrophobic domain on the TCL1 oncoprotein mediates association with AKT at the cytoplasmic membrane.
French SW; Shen RR; Koh PJ; Malone CS; Mallick P; Teitell MA
Biochemistry; 2002 May; 41(20):6376-82. PubMed ID: 12009899
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the co-activation of protein kinase B by T-cell leukemia-1 (TCL1) family proto-oncoproteins.
Auguin D; Barthe P; Royer C; Stern MH; Noguchi M; Arold ST; Roumestand C
J Biol Chem; 2004 Aug; 279(34):35890-902. PubMed ID: 15169787
[TBL] [Abstract][Full Text] [Related]
5. Identification of the TCL1/MTCP1-like 1 (TML1) gene from the region next to the TCL1 locus.
Sugimoto J; Hatakeyama T; Narducci MG; Russo G; Isobe M
Cancer Res; 1999 May; 59(10):2313-7. PubMed ID: 10344735
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of p14TCL1, an oncogene product involved in T-cell prolymphocytic leukemia, reveals a novel beta-barrel topology.
Hoh F; Yang YS; Guignard L; Padilla A; Stern MH; Lhoste JM; van Tilbeurgh H
Structure; 1998 Feb; 6(2):147-55. PubMed ID: 9519406
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of recombinant forms of murine Tcl1 proteins.
Du Bois GC; Song SP; Kulikovskaya I; Rothstein JL; Germann MW; Croce CM
Protein Expr Purif; 2000 Apr; 18(3):277-85. PubMed ID: 10733880
[TBL] [Abstract][Full Text] [Related]
8. The murine Tcl1 oncogene: embryonic and lymphoid cell expression.
Narducci MG; Virgilio L; Engiles JB; Buchberg AM; Billips L; Facchiano A; Croce CM; Russo G; Rothstein JL
Oncogene; 1997 Aug; 15(8):919-26. PubMed ID: 9285687
[TBL] [Abstract][Full Text] [Related]
9. Backbone dynamics and solution structure refinement of the 15N-labeled human oncogenic protein p13MTCP1: comparison with X-ray data.
Guignard L; Padilla A; Mispelter J; Yang YS; Stern MH; Lhoste JM; Roumestand C
J Biomol NMR; 2000 Jul; 17(3):215-30. PubMed ID: 10959629
[TBL] [Abstract][Full Text] [Related]
10. Proto-oncogene TCL1: more than just a coactivator for Akt.
Noguchi M; Ropars V; Roumestand C; Suizu F
FASEB J; 2007 Aug; 21(10):2273-84. PubMed ID: 17360849
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes.
Pekarsky Y; Hallas C; Isobe M; Russo G; Croce CM
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2949-51. PubMed ID: 10077617
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family.
Laine J; Künstle G; Obata T; Noguchi M
J Biol Chem; 2002 Feb; 277(5):3743-51. PubMed ID: 11707444
[TBL] [Abstract][Full Text] [Related]
13. The role of TCL1 in human T-cell leukemia.
Pekarsky Y; Hallas C; Croce CM
Oncogene; 2001 Sep; 20(40):5638-43. PubMed ID: 11607815
[TBL] [Abstract][Full Text] [Related]
14. The TCL1 family of oncoproteins: co-activators of transformation.
Teitell MA
Nat Rev Cancer; 2005 Aug; 5(8):640-8. PubMed ID: 16056259
[TBL] [Abstract][Full Text] [Related]
15. Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1.
Künstle G; Laine J; Pierron G; Kagami Si S; Nakajima H; Hoh F; Roumestand C; Stern MH; Noguchi M
Mol Cell Biol; 2002 Mar; 22(5):1513-25. PubMed ID: 11839817
[TBL] [Abstract][Full Text] [Related]
16. Expression of TCL1 in hematologic disorders.
Roos J; Hennig I; Schwaller J; Zbären J; Dummer R; Burg G; Tobler A; Virgilio L; Croce CM; Fey MF; Borisch B
Pathobiology; 2001; 69(2):59-66. PubMed ID: 11752899
[TBL] [Abstract][Full Text] [Related]
17. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation.
Pekarsky Y; Koval A; Hallas C; Bichi R; Tresini M; Malstrom S; Russo G; Tsichlis P; Croce CM
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3028-33. PubMed ID: 10716693
[TBL] [Abstract][Full Text] [Related]
18. Genomic analysis of human and mouse TCL1 loci reveals a complex of tightly clustered genes.
Hallas C; Pekarsky Y; Itoyama T; Varnum J; Bichi R; Rothstein JL; Croce CM
Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14418-23. PubMed ID: 10588720
[TBL] [Abstract][Full Text] [Related]
19. TCL1: a new drug target in lymphoid and germ-cell malignancies?
Lock RB
Int J Biochem Cell Biol; 2003 Dec; 35(12):1614-8. PubMed ID: 12962701
[TBL] [Abstract][Full Text] [Related]
20. Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.
Thick J; Metcalfe JA; Mak YF; Beatty D; Minegishi M; Dyer MJ; Lucas G; Taylor AM
Oncogene; 1996 Jan; 12(2):379-86. PubMed ID: 8570215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
